PATENT CLAIM ANALYSIS

Application Number: 16271689
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "134100"]

Abstract:
The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.

Claim (Index 3):
The method of  claim 2 , wherein the human albumin has an amino acid sequence identical to SEQ ID NO: 5.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 99.0
- Lexical Diversity: 2.13636
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16271686', '15043457', '14982934', '15890284', '13809276']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8197291390587186
- 35 USC 102 Novelty (BERT): 0.6305450133814069
- Combined Prediction Score: 0.8008107264909875
- Mean Citation Score: 881.1502200000001
- Max Citation Score: 891.02734
- Similarity Product: 526.9072818098758

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test